Probiodrug's Unattributed VC - III Round

Probiodrug raised a round of funding on October 17, 2000.

Probiodrug is dedicated to the discovery and development of small molecule drugs against novel molecular targets for the treatment of neuronal- and inflammatory diseases. The company develops therapeu…

Articles about Probiodrug's Unattributed VC - III Round: